Page last updated: 2024-09-03

bq 610 and 6-ketoprostaglandin f1 alpha

bq 610 has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies

Compound Research Comparison

Studies
(bq 610)
Trials
(bq 610)
Recent Studies (post-2010)
(bq 610)
Studies
(6-ketoprostaglandin f1 alpha)
Trials
(6-ketoprostaglandin f1 alpha)
Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha)
124134,832294150

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busija, DW; Miller, AW; Puskar, M; Tulbert, C1

Other Studies

1 other study(ies) available for bq 610 and 6-ketoprostaglandin f1 alpha

ArticleYear
Enhanced endothelin activity prevents vasodilation to insulin in insulin resistance.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Glyburide; In Vitro Techniques; Indomethacin; Insulin; Insulin Resistance; Male; Mesenteric Artery, Superior; Oligopeptides; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Vasodilation

2002
chemdatabank.com